Related references
Note: Only part of the references are listed.The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling
Xin Zheng et al.
GENES CHROMOSOMES & CANCER (2013)
The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3
Ian M. Love et al.
CELL CYCLE (2012)
The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism
Xin Zheng et al.
PLOS ONE (2012)
Activation of v-Myb Avian Myeloblastosis Viral Oncogene Homolog-Like2 (MYBL2)-LIN9 Complex Contributes to Human Hepatocarcinogenesis and Identifies a Subset of Hepatocellular Carcinoma with Mutant p53
Diego F. Calvisi et al.
HEPATOLOGY (2011)
Restoration of DNA-Binding and Growth-Suppressive Activity of Mutant Forms of p53 Via a PCAF-Mediated Acetylation Pathway
Ricardo E. Perez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
Mamta Gupta et al.
BLOOD (2009)
Histone acetylation Where to go and how to get there
Vicki E. MacDonald et al.
EPIGENETICS (2009)
Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation
Chunrong Yu et al.
CLINICAL CANCER RESEARCH (2007)
Role of histone acetylation in the control of gene expression
L Verdone et al.
BIOCHEMISTRY AND CELL BIOLOGY (2005)
Hepatocellular carcinoma: Molecular pathways and new therapeutic targets
LR Roberts et al.
SEMINARS IN LIVER DISEASE (2005)
Histone deacetylase inhibitors for treatment of hepatocellular carcinoma
D Coradini et al.
ACTA PHARMACOLOGICA SINICA (2005)
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But
D Coradini et al.
CLINICAL CANCER RESEARCH (2004)
Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line
KT Chan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
H El-Serag et al.
ANNALS OF INTERNAL MEDICINE (2003)
Histone, deacetylase inhibitor trichostatin a induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells
Y Yamashita et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Histone acetylation: a switch between repressive and permissive chromatin - Second in review series on chromatin dynamics
A Eberharter et al.
EMBO REPORTS (2002)
Histone acetylation and disease
S Timmermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Share Paper
